<--- Back to Details
First PageDocument Content
Juvenile myelomonocytic leukemia / Monocytic leukemia / Leukemia / Hematopoietic stem cell transplantation / Sideroblastic anemia / Chronic myelomonocytic leukemia / Myelomonocyte / Myelodysplastic syndrome / Acute myeloid leukemia / Medicine / Oncology / Myeloid leukemia
Date: 2003-04-25 11:34:22
Juvenile myelomonocytic leukemia
Monocytic leukemia
Leukemia
Hematopoietic stem cell transplantation
Sideroblastic anemia
Chronic myelomonocytic leukemia
Myelomonocyte
Myelodysplastic syndrome
Acute myeloid leukemia
Medicine
Oncology
Myeloid leukemia

Leukemia/MDS Transformation Patient Name ________________________________________ Patient Status Patient Initials / SCNIR # ______________________________

Add to Reading List

Source URL: depts.washington.edu

Download Document from Source Website

File Size: 77,07 KB

Share Document on Facebook

Similar Documents

Lifebank_Logo_withTag-centered

Lifebank_Logo_withTag-centered

DocID: 1rakV - View Document

NIH Public Access Author Manuscript Clin Lymphoma Myeloma. Author manuscript; available in PMC 2009 November 30. NIH-PA Author Manuscript

NIH Public Access Author Manuscript Clin Lymphoma Myeloma. Author manuscript; available in PMC 2009 November 30. NIH-PA Author Manuscript

DocID: 1qxR7 - View Document

Microsoft Word - blood_cancer_gene_sanger_institute_release

Microsoft Word - blood_cancer_gene_sanger_institute_release

DocID: 1qeRh - View Document

Needham & Company 15th Annual Healthcare Conference John Scarlett, M.D. President & CEO, Geron Corporation April 12, 2016

Needham & Company 15th Annual Healthcare Conference John Scarlett, M.D. President & CEO, Geron Corporation April 12, 2016

DocID: 1pn6V - View Document

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES www.mjhid.org ISSNOriginal Article Clinical Analysis and Optimization of Postremission Therapy for Acute Myeloid Leukemia Patients with Minimal Resid

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES www.mjhid.org ISSNOriginal Article Clinical Analysis and Optimization of Postremission Therapy for Acute Myeloid Leukemia Patients with Minimal Resid

DocID: 1oCtU - View Document